In 2023, LeapFrog Investments, one of Healthify’s largest backers, said the Bengaluru company was on track to become a billion-dollar business by 2026. The most recent regulatory filings tell a different story: revenue of ₹178 crore (~$18.5 million) for the year to March 2025, down for the third straight year running.
The company you know as HealthifyMe dropped the “Me” from its name in December 2023 and rebuilt itself around an AI coach called Ria. In the same period it cut its net loss by 95.0%, from ₹88 crore in FY24 to ₹4.7 crore in FY25 — not by growing, but by pulling back marketing spend by 82.3%. Both things are true at once: a company getting healthier on paper while its top line shrinks. This is the story of how that happened, and what it says about the business underneath the app.
Quick facts
| Company | Healthify (formerly HealthifyMe), HealthifyMe Wellness Private Limited |
| Founded | 2012, Bengaluru |
| Founder(s) | Tushar Vashisht (CEO), Sachin Shenoy, Mathew Cherian |
| Businesses | AI + human coaching subscriptions for nutrition and fitness, the Ria AI health assistant, connected devices (smart scales), export/international subscriptions, corporate wellness |
| Latest FY revenue | ₹178 crore (~$18.5 million), FY25 (year to March 2025) |
| Latest FY profit/loss | Net loss of ₹4.7 crore, FY25 |
| Listed | Private — no IPO announced |
| Market value / last valuation | Not publicly disclosed since its 2021 Series C; total equity raised reported between $125 million (company statement, October 2024) and $145 million (Tracxn, cumulative across rounds) |
| Key shareholders or CEO | Tushar Vashisht (co-founder and CEO); investors include Khosla Ventures, LeapFrog Investments, Claypond Capital, Unilever Ventures, Chiratae Ventures |
What they do
Healthify sells health coaching as a subscription. Users open the app, log meals by typing, scanning a barcode or photographing a plate, and get back a running tally of calories and macros alongside guidance from an AI assistant called Ria and, on paid tiers, a human nutritionist or fitness coach. The customer is anyone trying to lose weight, manage a condition such as diabetes or simply eat with more discipline; the company says it has more than 45 million registered users, mostly in India, with a smaller but growing base in the United States, as reported by TechCrunch in December 2025. Alongside the subscription, Healthify sells a connected smart scale and other devices, and licenses its coaching product to employers as a workplace wellness benefit.
The origin
Tushar Vashisht built the first version of what became HealthifyMe almost by accident. A University of Pennsylvania computer-science graduate who had worked at BlackRock and Deutsche Bank before joining the Aadhaar project in Bengaluru in 2009, Vashisht put on weight after moving back to India and started keeping an Excel sheet of foods and their calorie counts to track his own eating, according to his profile on Wikipedia. He and co-founder Mathew Cherian turned that spreadsheet into software; Sachin Shenoy, an engineer, joined about a year later as the company’s technical co-founder. The founding insight was narrow and personal — that counting calories in India, where meals are rarely packaged with nutrition labels and regional cuisines vary enormously, needed a purpose-built tool rather than an imported one. HealthifyMe launched as what it called India’s first comprehensive calorie tracker in 2012, then an Android app in 2013.
The struggle years
The company’s hardest stretch came just after its biggest fundraise. Flush with $75 million from a Series C round led by Khosla Ventures and LeapFrog Investments in July 2021, HealthifyMe spent aggressively to acquire users: advertisement and promotion costs jumped more than fivefold to ₹133.18 crore in FY22, according to regulatory filings reported by Entrackr in August 2022. Total costs nearly tripled to ₹343.44 crore that year, and the company was spending ₹1.85 to earn every rupee of operating revenue, up from ₹1.23 the year before. Net loss surged 8.26 times to ₹157 crore, and cash burn from operations spiked twentyfold to ₹84 crore. It was a classic growth-at-all-costs bet that had not yet paid off.
The correction came fast. In December 2022, HealthifyMe laid off around 150 employees — 15 to 20% of its workforce — in non-operations roles including marketing, product and quality analytics, as reported by YourStory and Outlook Business at the time. The company said the cuts were tied to a shift in strategy it called “HealthifyMe 2.0,” built around metabolic health rather than pure calorie tracking, and an explicit push toward profitability even though it said it had a comfortable cash runway. Revenue kept falling for two more years after that — from ₹229.7 crore in FY23 to ₹206.3 crore in FY24 to ₹178 crore in FY25 — even as the company insisted the business was getting healthier underneath.
The turning point
The clearest inflection point is the December 2023 rebrand from HealthifyMe to Healthify, which came bundled with “Ria 2.0,” a more capable AI coaching layer, and a partnership with food-delivery platform Swiggy to surface healthier ordering choices, reported by Afaqs. The rebrand marked a shift in self-description from a tracking app to a coaching platform, and it lined up with a visible change in the cost structure. In FY24, the company still spent ₹73.5 crore on advertising and business promotion while posting a ₹88 crore loss. A year later, in FY25, advertising spend was cut by 82.3% to ₹13 crore, employee benefit expense fell 30.0% to ₹59.5 crore, and total expenses dropped 38.0% to ₹182.6 crore — and the net loss collapsed by 95.0% to ₹4.7 crore, according to financial statements sourced from the Registrar of Companies and reported by Startuppedia. The company did not grow its way to near-breakeven; it cut its way there, mostly by spending far less to acquire the same shrinking base of paying users.
The money behind it
Healthify has raised money in roughly four phases. Early institutional rounds — a $6 million Series A in 2016 from IDG Ventures, Inventus Capital and Blume Ventures, and a $12–18 million Series B in 2018 led by Sistema Asia Fund and Samsung’s NEXT fund — got the product to scale in India. The big step up was the $75 million Series C in July 2021, led by Khosla Ventures and LeapFrog Investments, with HealthQuad, Unilever Ventures and Saudi Arabia’s PIF-linked Elm also participating, according to the company’s PRNewswire release; that round pushed cumulative funding past $100 million and was explicitly earmarked for expansion into Southeast Asia and North America. A $30 million pre-Series D round followed in June 2023 from the same two lead investors plus Unilever Ventures, Blume and Chiratae, and a further $45 million round closed in October 2024, adding Claypond Capital — the family office of Manipal Hospitals’ Ranjan Pai — as a new backer, specifically to fund the US launch, as reported by Business Standard and Entrackr.
Three investors stand out for what they changed rather than just the cheque size. Khosla Ventures, a repeat lead across three rounds, brought Silicon Valley credibility and is the investor CEO Tushar Vashisht has pointed to when discussing a possible future funding round tied to US traction, per TechCrunch’s December 2025 report. LeapFrog Investments, an emerging-markets impact investor, pushed the company’s positioning toward “preventive health” for underserved populations — LeapFrog noted in 2023 that roughly 80% of Healthify’s user base was low-income and more than half were women, and it was LeapFrog that made the billion-dollar-by-2026 prediction now sitting uncomfortably against the FY25 numbers. Claypond Capital’s entry in 2024 brought a healthcare-industry investor onto the cap table just as the company leaned into clinical-adjacent positioning, including a Novo Nordisk tie-up around GLP-1 weight-loss support. Healthify has not disclosed a valuation for any round since 2021, and no reporting found in this research pins a specific post-money figure to either the 2023 or 2024 rounds.
How it makes money
The core product is a subscription: users pay monthly or annually for tiers that range from AI-only coaching through Ria to plans bundled with a human nutritionist or trainer, with a US-specific AI plan launched at $20 a month, per TechCrunch. Layered on top are one-time device sales — the company sells a connected smart scale — and a smaller institutional channel selling coaching access to employers as a wellness benefit. Costs sit in three buckets: advertising to acquire subscribers, the coach workforce (Healthify said in October 2024 it employed more than 600 human coaches), and the technology stack behind Ria, which as of December 2025 ran on OpenAI’s Realtime API rather than a model the company owns outright. The margin, such as it is, comes from how much of a subscriber’s questions Ria can answer without routing to a paid human coach — the more the AI resolves on its own, the lower the marginal cost of serving each additional user. The part outsiders tend to get wrong is treating Healthify as a free calorie-counting app monetised through ads; in FY22, the year the company nearly burned itself out, advertising was in fact its single largest cost, not its revenue source. It is a coaching business with a tracking app as the front door, and it earns from the coaching, not from user attention.
The numbers
Four consecutive years of filings show a business that scaled fast, lost heavily, and then shrank its way toward breakeven. All figures are standalone operating figures from HealthifyMe Wellness Private Limited’s regulatory filings, as reported by Entrackr, YourStory and Startuppedia.
| Fiscal year (₹ crore) | Revenue | Net loss | Total expenses |
|---|---|---|---|
| FY22 | 185.3 | 157.0 | 343.4 |
| FY23 | 229.7 | 142.0 | 371.7 |
| FY24 | 206.3 | 88.0 | 295.0 |
| FY25 | 178.0 | 4.7 | 182.6 |
Revenue peaked in FY23 and has fallen every year since, a cumulative decline of 22.5% from FY23 to FY25. Losses moved in the opposite direction, down 96.7% over the same two years. Both trends were driven mainly by the expense side: total costs fell 50.9% from FY23 to FY25, considerably faster than revenue did.
Where the money comes from
Startuppedia’s breakdown of the FY25 filings splits revenue into three lines: domestic nutrition and wellness coaching at ₹99 crore, down 23.2% from ₹129 crore in FY24; nutrition and wellness devices at ₹18.6 crore, up 11.4% from ₹16.7 crore; and export sales — subscriptions and services sold outside India — holding roughly flat at ₹60 crore. The surprise is in that last line. Export sales did not fall the way the core Indian coaching business did, and by FY25 they accounted for roughly a third of total revenue even before Healthify’s US consumer app had properly launched — the company was still running an “alpha” test and planning a fuller US beta as of late 2024, per YourStory. A domestic coaching business that is shrinking, next to an international revenue line that is holding steady, is the clearest numeric argument for why the company is betting its next chapter on the United States rather than deepening its home market.
The risks
Three risks stand out. First, Healthify’s AI coach depends on a third party: as of December 2025 Ria Voice ran on OpenAI’s Realtime API, and while the company has said it could swap in other models, rebuilding a voice-native, 50-language coaching product around a different vendor mid-flight would not be free, per TechCrunch. Second, the FY25 turnaround was achieved by cutting spend, not by growing the paying user base — advertising fell 82.3% in a single year — and it is not yet demonstrated that revenue can grow again once marketing spend is restored to anywhere near its FY22–24 levels. Third, data handling: a 2019 HuffPost investigation found that after users accepted HealthifyMe’s privacy policy, personal data including medical conditions, weight, location and meal logs was shared with a third-party analytics vendor, and a security researcher quoted in that report said the policy’s language was written to preserve the company’s ability to keep monetising user data even after someone stopped using the app — a live reputational and regulatory exposure for a company now handling health data for paying US customers under a different privacy regime.
The takeaway
Healthify’s last four years are a case study in the difference between a growth story and a survival story, and how easily one gets mistaken for the other. The company spent 2021 and 2022 chasing the growth story — more users, more ad spend, a headline valuation-friendly raise — and nearly burned itself out doing it. What actually stabilised the business was the opposite instinct: naming the metabolic-health pivot, cutting the marketing budget almost to the bone, and letting revenue shrink rather than propping it up with unprofitable spend. A company that gets healthier by getting smaller is not the same as a company that is winning; it is a company that has stopped losing, which is a real achievement but a different one, and the US expansion now under way is the first real test of whether Healthify can grow again without repeating the mistake that nearly ended it in 2022.
Frequently asked questions
Is HealthifyMe the same company as Healthify?
Yes. HealthifyMe rebranded to Healthify in December 2023 as part of a shift from a calorie-tracking app to an AI-led coaching platform built around its assistant, Ria, as reported by Afaqs.
Who founded HealthifyMe and when?
Tushar Vashisht, Mathew Cherian and Sachin Shenoy founded the company in Bengaluru in 2012, starting with a personal spreadsheet of Indian foods and their calorie values, per Vashisht’s own account on Wikipedia.
Is Healthify profitable?
It is close. The company reported a net loss of ₹4.7 crore in FY25 (year to March 2025), down 95.0% from a loss of ₹88 crore in FY24, according to filings reported by Startuppedia. Revenue fell over the same period, so the improvement came mainly from cost cuts, not growth.
How much money has Healthify raised, and what is it worth?
Total funding is reported at $125 million by the company as of October 2024 and at $145 million cumulatively by Tracxn, a discrepancy likely tied to how venture debt and older rounds are counted. Healthify has not disclosed a valuation since its $75 million Series C round in July 2021.
Is Healthify available in the United States?
Yes, in a limited form. The company ran alpha tests and a beta launch of a US-focused AI plan through late 2024 and 2025, including a $20-a-month AI plan reported by TechCrunch in December 2025, and raised a $45 million round in October 2024 specifically earmarked to fund the US push.
Sources
Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).
- Entrackr, “HealthifyMe posts Rs 185 Cr revenue in FY22, losses surge 8X,” August 2022
- YourStory, “Healthify slashes net loss by 38% in FY24 as both revenue, employee headcount decline,” November 2024
- Startuppedia, “Bengaluru-Based Digital Health Platform Healthify Reports Rs 178 Cr Revenue in FY25; Losses Narrow 96%,” 2025
- YourStory / Outlook Business, reporting on HealthifyMe’s layoff of ~150 employees and “HealthifyMe 2.0” strategy shift, December 2022
- Afaqs, “Healthify rebrands itself, launches AI coach & collaborates with Swiggy,” December 2023
- PRNewswire, “HealthifyMe Raises USD 75 Million In Series C Round Led By LeapFrog And Khosla Ventures,” July 2021
- Entrackr, “HealthifyMe secures $30 Mn in a pre-Series D round,” June 2023
- Business Standard, “Indian startup Healthify closes $45 mn funding round to drive US expansion,” October 2024
- Entrackr, “Healthify raises $20 Mn, aims for US expansion,” October 2024
- BusinessToday, “Healthify raises Rs 378 crore in latest funding to drive US expansion, AI integration,” October 2024
- ImpactAlpha, “LeapFrog and Khosla Ventures reinvest in HealthifyMe to boost preventive health in India,” June 2023
- TechCrunch, “Healthify upgrades its AI assistant Ria with real-time conversation capabilities,” December 2025
- Wikipedia, “Tushar Vashisht” and “HealthifyMe,” accessed September 2026
- HuffPost, “Every Step You Take: India’s Fitness Apps Are Exploiting Users And Workers,” investigation into HealthifyMe data-sharing practices
- Tracxn, “HealthifyMe — Funding Rounds & List of Investors,” accessed September 2026
Found an error? Write to us and we’ll correct it in the open, dated, on the piece.

